Edgewise Therapeutics, Inc.
EWTX
$29.69
-$0.81-2.66%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 530.11M | 563.34M | 593.99M | 436.39M | 470.17M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 13.28M | 10.56M | 9.26M | 6.79M | 5.31M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 543.39M | 573.90M | 603.26M | 443.18M | 475.48M |
|
|
|||||
| Total Current Assets | 543.39M | 573.90M | 603.26M | 443.18M | 475.48M |
| Net Property, Plant & Equipment | 9.22M | 9.57M | 10.08M | 10.52M | 11.07M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 695.00K | 262.00K |
| Total Assets | 552.60M | 583.47M | 613.33M | 454.39M | 486.82M |
|
|
|||||
| Total Accounts Payable | 6.01M | 6.16M | 8.32M | 8.79M | 5.58M |
| Total Accrued Expenses | 20.35M | 14.48M | 11.57M | 11.33M | 17.29M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.01M | 1.01M | 1.00M | 1.00M | 996.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 27.37M | 21.65M | 20.90M | 21.12M | 23.86M |
|
|
|||||
| Total Current Liabilities | 27.37M | 21.65M | 20.90M | 21.12M | 23.86M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.98M | 3.17M | 3.37M | 3.56M | 3.74M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 30.35M | 24.82M | 24.26M | 24.67M | 27.60M |
|
|
|||||
| Common Stock & APIC | 1.07B | 1.05B | 1.04B | 848.69M | 837.37M |
| Retained Earnings | -546.37M | -496.16M | -455.49M | -419.37M | -378.58M |
| Treasury Stock & Other | 677.00K | 701.00K | 204.00K | 401.00K | 420.00K |
| Total Common Equity | 522.26M | 558.65M | 589.07M | 429.72M | 459.22M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 522.26M | 558.65M | 589.07M | 429.72M | 459.22M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 522.26M | 558.65M | 589.07M | 429.72M | 459.22M |
|
|
|||||